Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

The cholesterol biosynthesis enzyme FAXDC2 couples Wnt/β-catenin to RTK/MAPK signaling

Madan, Babita, Wadia, Shawn R., Patnaik, Siddhi, Harmston, Nathan, Tan, Emile, Tan, Iain Bee Huat, Nes, W. David, Petretto, Enrico and Virshup, David M. 2024. The cholesterol biosynthesis enzyme FAXDC2 couples Wnt/β-catenin to RTK/MAPK signaling. The Journal of Clinical Investigation 134 (6) , e171222. 10.1172/JCI171222

[thumbnail of 171222.2-20240313141845-covered-e0fd13ba177f913fd3156f593ead4cfd (1).pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (15MB) | Preview

Abstract

Wnts, cholesterol, and MAPK signaling are essential for development and adult homeostasis. Here, we report that fatty acid hydroxylase domain containing 2 (FAXDC2), a previously uncharacterized enzyme, functions as a methyl sterol oxidase catalyzing C4 demethylation in the Kandutsch-Russell branch of the cholesterol biosynthesis pathway. FAXDC2, a paralog of MSMO1, regulated the abundance of the specific C4-methyl sterols lophenol and dihydro-T-MAS. Highlighting its clinical relevance, FAXDC2 was repressed in Wnt/β-catenin–high cancer xenografts, in a mouse genetic model of Wnt activation, and in human colorectal cancers. Moreover, in primary human colorectal cancers, the sterol lophenol, regulated by FAXDC2, accumulated in the cancerous tissues and not in adjacent normal tissues. FAXDC2 linked Wnts to RTK/MAPK signaling. Wnt inhibition drove increased recycling of RTKs and activation of the MAPK pathway, and this required FAXDC2. Blocking Wnt signaling in Wnt-high cancers caused both differentiation and senescence; and this was prevented by knockout of FAXDC2. Our data show the integration of 3 ancient pathways, Wnts, cholesterol synthesis, and RTK/MAPK signaling, in cellular proliferation and differentiation.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
Publisher: American Society for Clinical Investigation
ISSN: 1558-8238
Date of First Compliant Deposit: 28 March 2024
Date of Acceptance: 17 January 2024
Last Modified: 21 May 2024 11:08
URI: https://orca.cardiff.ac.uk/id/eprint/167609

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics